Physician profile
Linh N Nguyen
NPI 1528083615
$4,424.85
in general payments reported to CMS, 2019-2025
41 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 86% of Therapeutic Radiology providers received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,898 · 2024: $1,329 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,350 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,349.85 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $1,559.16 | 2023-2025 | Cabometyx |
| Astrazeneca Pharmaceuticals Lp | $519.05 | 2023-2025 | Lynparza, Imfinzi, Farxiga |
| Novartis Pharmaceuticals Corporation | $238.11 | 2024-2025 | |
| Incyte Corporation | $205.74 | 2023-2025 | Jakafi, Monjuvi, Zynyz |
| Janssen Biotech, INC. | $184.87 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Genzyme Corporation | $148.99 | 2024-2025 | |
| Astellas Pharma US INC | $128.50 | 2023-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $100.78 | 2023-2024 | Alunbrig, Ninlaro |
| Servier Pharmaceuticals LLC | $89.12 | 2023-2025 | |
| Sobi, INC | $89.10 | 2024-2025 | |
| Daiichi Sankyo INC. | $86.98 | 2023-2025 | Enhertu |
| Eisai INC. | $85.02 | 2023-2024 | |
| Seagen INC. | $75.77 | 2023 | Tukysa, Adcetris |
| Alexion Pharmaceuticals, INC. | $75.21 | 2023-2024 | Ultomiris |
| Merck Sharp & Dohme LLC | $60.55 | 2024 | Keytruda, Welireg |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linh Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.